| FIELD OF APPLICATION | DETAILS |
|---|---|
| Generic Name | Oxyphencyclimine |
| Active Ingredient | Oxyphencyclimine hydrochloride |
| US Brand Names | Daricon |
| Drug Category | Gastroenterology |
| Drug Class | Palliative treatment, Immunosuppressive therapy |
| Route of Administration | Oral |
| Initial FDA Approval Date | FDA Approved (January 1959); Withdrawn (September 1999) |
Oxyphencyclimine: Overview
Oxyphencyclimine belongs to the class of organic compounds known as hydropyrimidines. These are organic compounds containing a hydrogenated pyrimidine ring structure. Chemically, it is classified as a synthetic anticholinergic agent equipped with a tertiary amino group ester, which allows it to exert distinct pharmacological actions on the peripheral and central nervous systems.
In clinical gastroenterology, oxyphencyclimine was historically utilized as a potent antispasmodic and antiulcer medication. It was prescribed to manage peptic ulcer disease and to relieve severe smooth muscle spasticity across the gastrointestinal tract. By relaxing the smooth muscles of the digestive system and reducing gastric acid secretion, it provided symptomatic relief for patients suffering from acute gastrointestinal disorders.
Oxyphencyclimine: What Is It & How Does It Work?
Oxyphencyclimine functions as a broad spectrum anticholinergic agent that blocks the action of acetylcholine across multiple receptor sites in the body:
- Muscarinic Receptor Antagonism: It competitively binds to and blocks muscarinic acetylcholine receptors. It is known to block M1 receptors in the central nervous system, M2 receptors in the heart, and M3 receptors at the parasympathetic neuroeffector junctions in the digestive tract.
- Smooth Muscle Relaxation: By antagonizing these receptors, it inhibits vagally mediated reflexes. This blockade directly reduces the contraction and spasticity of the smooth muscle tissue lining the stomach and intestines.
- Reduction of Gastric Secretions: The antagonism of acetylcholine at the gastric level significantly decreases the overall secretion volume and acidity of gastric fluids, facilitating the healing of peptic ulcers.
- Cellular Pathway Modulation: The blockade of muscarinic receptors prevents cellular responses such as the inhibition of adenylate cyclase and the breakdown of phosphoinositides, thus stabilizing smooth muscle tone.
Oxyphencyclimine: FDA Approval & Uses
Understanding the regulatory status of oxyphencyclimine clarifies its historical role in managing gastrointestinal disorders.
Global Regulatory Status
Yes. Oxyphencyclimine was historically an FDA approved medication in the United States, although it was later voluntarily withdrawn from the market by its manufacturer.
Primary Indications
During its commercial availability, oxyphencyclimine was indicated for the following clinical purposes:
- Smooth Muscle Spasticity: Prescribed for the relief of painful smooth muscle spasms in various gastrointestinal disorders.
- Peptic Ulcer Disease: Used as an adjunct therapy to reduce stomach acid production and facilitate the healing of gastric and duodenal ulcers.
Before Taking Oxyphencyclimine: Contraindications & Precautions
Before starting treatment with oxyphencyclimine, patients must review key safety precautions and underlying health risks with their healthcare provider.
Who Should Not Take Oxyphencyclimine?
- Individuals with a known severe hypersensitivity or allergic reaction to oxyphencyclimine or other synthetic anticholinergic agents.
- Patients with narrow angle glaucoma, as anticholinergic drugs can cause a dangerous increase in intraocular pressure.
- Individuals suffering from severe urinary retention, benign prostatic hyperplasia, or gastrointestinal obstruction, as the medication severely slows down bodily tract motility.
- Patients with myasthenia gravis, because blocking acetylcholine receptors will dangerously exacerbate muscle weakness.
Oxyphencyclimine: Pregnancy & Breastfeeding
The safety of oxyphencyclimine during pregnancy was never fully established in comprehensive modern clinical trials. It was generally advised to be used during pregnancy only when the clinical benefits clearly outweighed the unknown risks to the developing fetus. Furthermore, anticholinergic medications can suppress the production of breast milk and may be excreted into human milk, making it contraindicated for nursing mothers.
Tell Your Doctor Before Taking Oxyphencyclimine
Inform your gastroenterologist if you have a history of cardiovascular disease, irregular heartbeats, hyperthyroidism, high blood pressure, or a hiatal hernia associated with reflux esophagitis before beginning any anticholinergic therapy.
Oxyphencyclimine: Dosage & Administration
Because oxyphencyclimine carries significant systemic anticholinergic effects, dosing was managed carefully within a clinical environment.
Standard Oxyphencyclimine Dosing
- Standard Adult Dosing: The typical oral dose was ten milligrams taken twice daily, usually in the morning and at bedtime, to provide continuous suppression of gastric acid and muscle spasms.
How Oxyphencyclimine Is Administered
- Dosage Forms: It was commercially supplied as an oral Tablet.
- Administration Routes: Administered exclusively via the Oral route. It was generally recommended to be taken with a full glass of water.
Oxyphencyclimine: Clinical Efficacy & Research
Clinical trials and historical studies establish the antispasmodic and antisecretory efficacy of tertiary amine anticholinergics. Research highlights its capacity to reduce basal and stimulated gastric acid output over extended durations.
Trial Findings and Efficacy
During its active clinical lifespan, oxyphencyclimine was a reliable and effective treatment for gastrointestinal spasticity. Clinical trials demonstrated that its synthetic tertiary amine structure provided a long duration of action, making twice daily dosing sufficient for most patients. By effectively blocking vagal stimulation to the gut, it successfully reduced basal and stimulated gastric acid secretion, promoting the rapid healing of peptic ulcers prior to the advent of modern proton pump inhibitors.
Oxyphencyclimine: Side Effects & Safety Profile
Oxyphencyclimine did not carry a specific FDA Black Box Warning prior to its discontinuation. However, all potent systemic anticholinergic drugs carry severe clinical warnings regarding the risks of fatal hyperthermia in hot climates, acute urinary retention in elderly males, and the potential for paralytic ileus in patients with pre existing bowel dysmotility.
Understanding the side effect profile of oxyphencyclimine helps clinical teams and patients manage safety parameters during administration. Because oxyphencyclimine blocks muscarinic receptors systemically, it carries a prominent and predictable anticholinergic side effect profile.
Common Oxyphencyclimine Side Effects
- Dry mouth and decreased sweating.
- Blurred vision and sensitivity to bright light.
- Constipation and decreased gastrointestinal motility.
- Mild dizziness, drowsiness, or a feeling of lightheadedness.
Serious Oxyphencyclimine Adverse Events
- Severe Urinary Retention: A complete inability to empty the bladder, requiring immediate medical catheterization.
- Paralytic Ileus: A dangerous cessation of all intestinal movement, leading to severe abdominal pain and bowel obstruction.
- Hyperthermia: A potentially fatal elevation in body temperature caused by the drug inhibiting the sweat glands, particularly dangerous during summer months.
- Tachycardia: Rapid or irregular heartbeats due to the blockade of M2 receptors in the heart.
Managing Oxyphencyclimine Side Effects
Patients were advised to chew sugarless gum or sip water frequently to alleviate severe dry mouth. If a patient experienced eye pain, extreme constipation, or an inability to urinate, the medication had to be stopped immediately and medical attention sought.
Oxyphencyclimine: Drug Interactions & What to Avoid
Oxyphencyclimine interacts significantly with central nervous system depressants, anticholinergic drugs, and prokinetic agents.
Key Oxyphencyclimine Interactions
- Tricyclic Antidepressants and Antihistamines: Using this drug alongside other anticholinergics causes an additive effect, exponentially increasing the risk of severe dry mouth, constipation, and urinary retention.
- Gastrointestinal Prokinetics: It directly antagonizes drugs designed to speed up gut motility, rendering medications like metoclopramide completely ineffective.
- Liquid Antacids: Concurrent administration with liquid antacids can impair the intestinal absorption of the medication, reducing its clinical effectiveness.
Oxyphencyclimine: Food & Alcohol
Patients were strictly warned to avoid alcohol consumption. Alcohol synergistically increases the central nervous system side effects of anticholinergic drugs, leading to profound drowsiness and impaired cognitive function.
Oxyphencyclimine: Missed Dose, Overdose & Storage
Proper facility handling, security, and administration protocols govern anticholinergic management.
Missed Dose of Oxyphencyclimine
If a dose was missed, patients were advised to take it as soon as they remembered. If it was nearing the time for the next scheduled dose, the missed dose was skipped entirely. Taking a double dose was strictly prohibited to prevent acute anticholinergic toxicity.
Oxyphencyclimine Overdose
An overdose is a severe medical emergency resulting in acute anticholinergic poisoning. Symptoms included severely blurred vision, dilated pupils, flushed and hot dry skin, extreme dry mouth, rapid heart rate, confusion, and delirium. Emergency treatment involved immediate gastric lavage, cardiovascular support, and the administration of a specific antidote such as physostigmine.
How to Store Oxyphencyclimine
The oral tablets were stored at controlled room temperature in a tightly closed container, protected from excessive heat and moisture, and kept securely out of the reach of children.
Oxyphencyclimine: Patient Management & Guidelines
Effective clinical management relies on routine monitoring of intraocular pressure and heart rate metrics.
Tests Before & During Oxyphencyclimine Treatment
- Intraocular Pressure Screening: Elderly patients were required to have their eye pressure checked prior to initiating therapy to rule out undiagnosed glaucoma.
- Heart Rate Monitoring: Routine checks of pulse and blood pressure, especially in patients with known cardiac arrhythmias.
Oxyphencyclimine: Do’s and Don’ts
- Do stay well hydrated and stay in air conditioned environments during hot weather to prevent heatstroke.
- Do take the medication exactly as prescribed by your gastroenterologist.
- Do not drive a vehicle or operate heavy machinery if you experience blurred vision or dizziness.
- Do not use over the counter cold or allergy medications without consulting a pharmacist to prevent severe drug interactions.
Frequently Asked Questions
What was Oxyphencyclimine used for?
It was a prescription medication used to relieve severe stomach cramps and intestinal muscle spasms, and to help heal peptic ulcers.
How did Oxyphencyclimine heal stomach ulcers?
It worked by blocking specific nerve signals in the stomach, which reduced the amount of digestive acid produced and relaxed the surrounding stomach muscles to allow the ulcer to heal.
Why is Oxyphencyclimine no longer available in the United States?
The drug was voluntarily withdrawn by its manufacturer, largely because newer, safer, and much more effective medications like proton pump inhibitors were developed to treat ulcers and acid related disorders.
Could this medication cause vision problems?
Yes. It commonly caused blurred vision and dilated pupils by relaxing the muscles in the eyes, which made it dangerous for people suffering from glaucoma.
Why did patients have to be careful in hot weather while taking it?
The medication blocked the body from sweating properly. In hot weather, this could cause a dangerous and rapid increase in body temperature known as hyperthermia.
Did it cause memory problems in older adults?
Yes. Because it blocked acetylcholine in the brain, elderly patients were highly susceptible to side effects like confusion, memory loss, and severe dizziness.
References
- DrugBank Database – Oxyphencyclimine Clinical and Pharmacological Profile
- U.S. Food and Drug Administration Regulatory Archives on Anticholinergic Agents
- Clinical Guidelines for the Management of Functional Gastrointestinal Disorders
Legal Disclaimer
The information provided is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider regarding medical conditions or treatment plans.



